149 related articles for article (PubMed ID: 36223119)
1. Sensitivity and Diagnostic Yield of the First SARS-CoV-2 Nucleic Acid Amplification Test Performed for Patients Presenting to the Hospital.
Hohl CM; Hau JP; Vaillancourt S; Grant J; Brooks SC; Morrison LJ; Perry JJ; Rosychuk RJ;
JAMA Netw Open; 2022 Oct; 5(10):e2236288. PubMed ID: 36223119
[TBL] [Abstract][Full Text] [Related]
2. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.
Harvey RA; Rassen JA; Kabelac CA; Turenne W; Leonard S; Klesh R; Meyer WA; Kaufman HW; Anderson S; Cohen O; Petkov VI; Cronin KA; Van Dyke AL; Lowy DR; Sharpless NE; Penberthy LT
JAMA Intern Med; 2021 May; 181(5):672-679. PubMed ID: 33625463
[TBL] [Abstract][Full Text] [Related]
3. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic yield of screening for SARS-CoV-2 among patients admitted to hospital for alternate diagnoses: an observational cohort study.
Davis P; Rosychuk R; Hau JP; Cheng I; McRae AD; Daoust R; Lang E; Turner J; Khangura J; Fok PT; Stachura M; Brar B; Hohl CM;
BMJ Open; 2022 Aug; 12(8):e057852. PubMed ID: 35948378
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis.
Butler-Laporte G; Lawandi A; Schiller I; Yao M; Dendukuri N; McDonald EG; Lee TC
JAMA Intern Med; 2021 Mar; 181(3):353-360. PubMed ID: 33449069
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
7. CCEDRRN COVID-19 Infection Score (CCIS): development and validation in a Canadian cohort of a clinical risk score to predict SARS-CoV-2 infection in patients presenting to the emergency department with suspected COVID-19.
McRae AD; Hohl CM; Rosychuk R; Vatanpour S; Ghaderi G; Archambault PM; Brooks SC; Cheng I; Davis P; Hayward J; Lang E; Ohle R; Rowe B; Welsford M; Yadav K; Morrison LJ; Perry J;
BMJ Open; 2021 Dec; 11(12):e055832. PubMed ID: 34857584
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
Kernéis S; Elie C; Fourgeaud J; Choupeaux L; Delarue SM; Alby ML; Quentin P; Pavie J; Brazille P; Néré ML; Minier M; Gabassi A; Gibaud A; Gauthier S; Leroy C; Voirin-Mathieu E; Poyart C; Vidaud M; Parfait B; Delaugerre C; Tréluyer JM; LeGoff J
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2379-2388. PubMed ID: 34342768
[TBL] [Abstract][Full Text] [Related]
9. Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
Cybulski DJ; Matthews Z; Kieffer JW; Casey TM; Osuna AB; Kasper K; Frankel DN; Aden J; Yun HC; Marcus JE
Clin Infect Dis; 2024 Jan; 78(1):65-69. PubMed ID: 37610361
[TBL] [Abstract][Full Text] [Related]
10. What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life.
Roger S; Lefeuvre C; Pivert A; Ducancelle A; Savary D; Bouthry É; Le Guillou-Guillemette H
J Med Virol; 2022 Apr; 94(4):1723-1727. PubMed ID: 34873718
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020.
Brihn A; Chang J; OYong K; Balter S; Terashita D; Rubin Z; Yeganeh N
MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):702-706. PubMed ID: 33983916
[TBL] [Abstract][Full Text] [Related]
12. Indications for SARS-CoV-2 nucleic acid amplification test for areas with low endemicity.
Higo H; Taguchi Y; Suzaki N; Nagata T; Marukawa M
J Infect Chemother; 2022 Feb; 28(2):238-241. PubMed ID: 34776347
[TBL] [Abstract][Full Text] [Related]
13. Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume.
Gawron AJ; Sultan S; Glorioso TJ; Califano S; Kralovic SM; Jones M; Kirsh S; Dominitz JA
Gastrointest Endosc; 2022 Sep; 96(3):423-432.e7. PubMed ID: 35461889
[TBL] [Abstract][Full Text] [Related]
14. Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.
Delgado-Diaz DJ; Sakthivel D; Nguyen HHT; Farrokzhad K; Hopper W; Narh CA; Richards JS
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746782
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany.
Wolf F; Matthes A; Markwart R; Bleidorn J
Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():43-49. PubMed ID: 36372644
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department.
Möckel M; Corman VM; Stegemann MS; Hofmann J; Stein A; Jones TC; Gastmeier P; Seybold J; Offermann R; Bachmann U; Lindner T; Bauer W; Drosten C; Rosen A; Somasundaram R
Biomarkers; 2021 May; 26(3):213-220. PubMed ID: 33455451
[TBL] [Abstract][Full Text] [Related]
17. Back to normal; serological testing for COVID-19 diagnosis unveils missed infections.
Tsuchida T; Nitahara Y; Suzuki S; Komase Y; Candray K; Kido Y; Nakagama Y; Yamasaki Y; Imamura M; Kawahata K; Kunishima H; Fujitani S; Mineshita M; Matsuda T
J Med Virol; 2021 Jul; 93(7):4549-4552. PubMed ID: 33739483
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of 2 Rapid Antigen Tests During 3 Phases of SARS-CoV-2 Variants.
Drain PK; Bemer M; Morton JF; Dalmat R; Abdille H; Thomas KK; Uppal TK; Hau D; Green HR; Gates-Hollingsworth MA; AuCoin DP; Verma SC
JAMA Netw Open; 2022 Aug; 5(8):e2228143. PubMed ID: 36001317
[TBL] [Abstract][Full Text] [Related]
19. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
[TBL] [Abstract][Full Text] [Related]
20. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
